In particular, they showed that C4PY elicits an inhibitory action on GPER-activated signaling, including the repression of both ERK and Akt phosphorylation, gene transcription, cell proliferation and migration in breast cancer cells and in CAFs. This evidence concerns the gene AKT1 and breast cancer.